The executive team at Nektar Therapeutics has a history of experience in the fields of neuroscience, pharmacy, medicine, and oriental medicine. They have also held positions in investor relations and as a patent attorney associate. In addition, they have been a member of the board of directors for various companies, including CLS, Tumbleweed Communications, Catellus Development Corporation, RayzeBio, Enzo Biochem Inc., and Chief. They have also served as a consultant-project team lead for InterMune's Expanded Access Program.
View all